首页> 外国专利> SYNAPTOTAGMIN AND COLLAPSIN RESPONSE MEDIATOR PROTEIN AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY

SYNAPTOTAGMIN AND COLLAPSIN RESPONSE MEDIATOR PROTEIN AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY

机译:突触素和胶原蛋白反应介质作为创伤性脑损伤的生物标志物

摘要

Collapsin response mediator proteins (CRMPs) decreased in tissue and increased in biological samples after neural injury from traumatic brain injury (TBI). Significant decreases of CRMP1, CRMP2, CRMP4 and CRMP5 were accompanied by the appearance of distinct 58 kDa (CRMP-2) or 55 kDa (CRMP-4) breakdown products from proteolytic cleavage by calpain. Synaptotagmin breakdown products were also associated with TBI and could be detected along with intact protein in human cerebral spinal fluid (biological samples). Both biomarkers were detected in human biofluid and related to recovery from traumatic brain injury.
机译:创伤性脑损伤(TBI)造成神经损伤后,组织中的胶原蛋白反应介导蛋白(CRMPs)减少,生物学样品中的胶原蛋白增加。 CRMP1,CRMP2,CRMP4和CRMP5的显着减少伴随钙蛋白酶蛋白酶解切割产生的明显的58 kDa(CRMP-2)或55 kDa(CRMP-4)分解产物出现。突触结合蛋白分解产物也与TBI有关,并且可以在人脑脊髓液(生物样品)中检测到完整蛋白。两种生物标志物均在人类生物流体中检测到,并与脑外伤的恢复有关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号